ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mrs. Eva - What is it?

Patient basic information Patient: Mrs. Eva King) Nationality: Albania Disease diagnosis: Lymphoma Diagnostic Hospital: H0C0 treatment program: Immunotherapy + targeted treatment Household days: 45 days Treatment cost: about 501341 yuan Treatment effect: surgical success Upon arrival, the International Medical Service Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process. During the treatment process, the International Medical Service Team employed a comprehensive set of immunotherapies + targeted therapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs.

After 45 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results The patient's final surgical success. When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to follow the recovery through the remote follow-up system.

'Mrs. Eva Liu, experts have criticized the case as a typical case of cross-border suspected seriousness clinical disease. Liu4 Liu is a multidisciplinary collaborative mechanism that develops immunotherapy+focused therapies for lymphoma, reflecting the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a shortened version of how international medical services are regulated.

(Figure from Liu5 Liu's official news report and medical scene)

阿尔巴尼亚,淋巴瘤,山东大学齐鲁医院,国际医疗,来华就医,中国医疗